Reduction in T cell apoptosis in patients with HIV disease following antiretroviral therapy

被引:39
作者
Chavan, SJ
Tamma, SL
Kaplan, M
Gersten, M
Pahwa, SG
机构
[1] NYU, Sch Med, N Shore Univ Hosp, Dept Pediat,Div Allergy Immunol, Manhasset, NY 11030 USA
[2] NYU, Sch Med, N Shore Univ Hosp, Dept Med, Manhasset, NY 11030 USA
[3] Agouron Pharmaceut Inc, La Jolla, CA 92037 USA
关键词
human; T-lymphocytes; apoptosis; HIV/AIDS; FACS;
D O I
10.1006/clim.1999.4770
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Patients with HIV infection manifest increased T lymphocyte apoptosis, This study investigated the influence of antiretroviral therapy (ART) upon lymphocyte apoptosis in 23 HIV-infected adults naive to protease inhibitors. Patients were enrolled in a treatment trial consisting of Nelfinavir (NFV), d4T, or NFV + d4T for 24 weeks, followed by triple therapy (NFV + reverse transcriptase inhibitors) for an additional 24 weeks. Spontaneous T cell apoptosis in cultured PBMC decreased by 23.67 +/- 18.2% (P < 0.006) at 48 weeks and plasma HIV RNA decreased by 1.79 +/- 0.59 log,, RNA copies/ml (P < 0.001). The absolute decrease and slope of T cell apoptosis correlated with plasma virus load and with activated CD8 T cells and was inversely correlated with CD4 T cells. We conclude that reduction in chronic antigenic stimulation and the absence of cellular signals elicited by viral products contribute to the rescue of T lymphocytes from apoptosis, which facilitates immunologic recovery in ART-treated patients. (C) 1999 Academic Press.
引用
收藏
页码:24 / 33
页数:10
相关论文
共 57 条
  • [1] AMEISEN JC, 1995, ADV EXP MED BIOL, V374, P139
  • [2] Aries SP, 1998, SCAND J IMMUNOL, V48, P86, DOI 10.1046/j.1365-3083.1998.00347.x
  • [3] Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease
    Autran, B
    Carcelain, G
    Li, TS
    Blanc, C
    Mathez, D
    Tubiana, R
    Katlama, C
    Debre, P
    Leibowitch, J
    [J]. SCIENCE, 1997, 277 (5322) : 112 - 116
  • [4] In vivo analysis of Fas/FasL interactions in HIV-infected patients
    Badley, AD
    Dockrell, DH
    Algeciras, A
    Ziesmer, S
    Landay, A
    Lederman, MM
    Connick, E
    Kessler, H
    Kuritzkes, D
    Lynch, DH
    Roche, P
    Yagita, H
    Paya, CV
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (01) : 79 - 87
  • [5] Upregulation of fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes
    Badley, AD
    McElhinny, JA
    Leibson, PJ
    Lynch, DH
    Alderson, MR
    Paya, CV
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (01) : 199 - 206
  • [6] Macrophage-dependent apoptosis of CD4(+) T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor
    Badley, AD
    Dockrell, D
    Simpson, M
    Schut, R
    Lynch, DH
    Leibson, P
    Paya, CV
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01) : 55 - 64
  • [7] Impaired induction of the apoptosis-protective protein Bcl-x(L) in activated PBMC from asymptomatic HIV-infected individuals
    Blair, PJ
    Boise, LH
    Perfetto, SP
    Levine, BL
    McCrary, G
    Wagner, KF
    StLouis, DC
    Thompson, CB
    Siegel, JN
    June, CH
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 1997, 17 (03) : 234 - 246
  • [8] CD95-induced apoptosis contributes to loss of primed/memory but not resting/naive T cells in children infected with human immunodeficiency virus type 1
    Böhler T.
    Nedel S.
    Debatin K.-M.
    [J]. Pediatric Research, 1997, 41 (6) : 878 - 885
  • [9] Downregulation of increased CD95 (APO-1/Fas) ligand in T cells from human immunodeficiency virus-type 1-infected children after antiretroviral therapy
    Bohler, T
    Herr, I
    Debatin, KM
    Geiss, M
    Haas, J
    [J]. BLOOD, 1997, 90 (02) : 886 - 887
  • [10] Boudet F, 1996, J IMMUNOL, V156, P2282